Kura Oncology Inc Sustainability Reports
Kura Oncology Inc. is a biopharmaceutical company engaged in discovering and developing precision medicines for the treatment of cancer. The company focuses on pipeline candidates targeting cell signaling pathways, including its lead oral menin inhibitor.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 5493005QORQTZCZYOP39
FIGI: BBG008974351
4 reports from 2020 to 2024
